Neurocutaneous melanocytosis (Q93770): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/403221860 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_403221860
Property / CURIE: CID11:ID_403221860 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_403221860
Property / Canary Token: dki-india-ID_403221860 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 08:52, 16 August 2026

Neurocutaneous melanocytosis (NCM) is a rare congenital neurological disorder characterised by abnormal aggregations of naevomelanocytes within the central nervous system (leptomeningeal melanocytosis) associated with large or giant congenital melanocytic naevi (CMN; see this term). NCM can be asymptomatic or present as variably severe and progressive neurological impairment, sometimes resulting in death. Prevalence is estimated at 1/50,000-1/200,000. The incidence of symptomatic NCM appears to be approximately a third to a half of these.
Language Label Description Also known as
default for all languages
ID_403221860
    English
    Neurocutaneous melanocytosis
    Neurocutaneous melanocytosis (NCM) is a rare congenital neurological disorder characterised by abnormal aggregations of naevomelanocytes within the central nervous system (leptomeningeal melanocytosis) associated with large or giant congenital melanocytic naevi (CMN; see this term). NCM can be asymptomatic or present as variably severe and progressive neurological impairment, sometimes resulting in death. Prevalence is estimated at 1/50,000-1/200,000. The incidence of symptomatic NCM appears to be approximately a third to a half of these.

      Statements

      CID11:ID_403221860
      0 references
      dki-india-ID_403221860
      0 references
      Concluído
      0 references
      15 August 2026
      0 references